| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-15 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-13 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-15 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-11 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-12 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-11 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-13 |